| abstract |
Disclosed are compositions and methods related to or derived from anti-c-Met antibodies. More specifically, fully human antibodies that bind c-Met, c-Met binding fragments and derivatives of the antibodies, and c-Met binding polypeptides comprising the fragments are disclosed. Furthermore, nucleic acids encoding the antibodies, antibody fragments and derivatives and polypeptides, cells containing the polynucleotides, methods for producing the antibodies, antibody fragments and derivatives and polypeptides, and various inflammatory disorders and various cancers Disclosed are methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing a subject having a c-Met related disorder or condition comprising: |